Impaired TRPM3 surface expression and function, reduced intracellular Ca2+ concentrations in natural killer (NK) cells and B lymphocytes [7], and dysregulated Ca2+ signalling are consistent findings in the NK cells of ME/CFS patients [7,8,9]. The gene discussed is TRPM3; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.